China Pharma Holdings (CPHI) Shares Outstanding (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly Shares Outstanding (Entity) came in at $25.6 million in Q1 2026, up 684.88% YoY from $3.3 million in Q1 2025, and up 496.58% on a QoQ basis from $4.3 million in Q4 2025.
China Pharma Holdings (CPHI) Shares Outstanding (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Shares Outstanding (Entity) data on file, last reported at $25.6 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 684.88% year-over-year to $25.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.6 million (up 684.88% YoY) and the FY2025 annual result came in at $4.3 million, up 145.73% from the prior year.
- Shares Outstanding (Entity) climbed to $25.6 million in Q1 2026, from $4.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $25.6 million in Q1 2026 to a low of $96600.0 in Q1 2022.
- A 5-year average of $2.8 million and a median of $1.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 5.97% — and 2024, when it soared 776.74%.
- Tracing CPHI's Shares Outstanding (Entity) over 5 years: stood at $105137.0 in 2022, then jumped by 221.82% to $338357.0 in 2023, then soared by 416.13% to $1.7 million in 2024, then surged by 145.73% to $4.3 million in 2025, then soared by 496.58% to $25.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $25.6 million (Q1 2026), $4.3 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | 40.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.60 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Sep 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Mar 31, 2025 | 3.26 Mn |
| Dec 31, 2024 | 1.75 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 338,357.00 |
| Sep 30, 2023 | 264,327.00 |
| Jun 30, 2023 | 198,324.00 |
| Mar 31, 2023 | 161,576.00 |
| Dec 31, 2022 | 105,137.00 |
| Sep 30, 2022 | 100,032.00 |
| Jun 30, 2022 | 96,977.00 |
| Mar 31, 2022 | 94,736.00 |
| Dec 31, 2021 | 92,259.00 |
| Sep 30, 2021 | 92,001.00 |
| Jun 30, 2021 | 91,159.00 |